Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Ranbaxy
Current Parent Company: Sun Pharmaceuticals
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $266,729,715
Year: 2013
Date: May 13, 2013
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Ranbaxy paid $266 million to resolve multistate litigation alleging that it sold generic drugs that lacked necessary active ingredients due to poor quality control standards to customers including state Medicaid programs. This was part of a larger $500 million civil and criminal settlement that involved the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: India
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.